IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Study Assessing the Safety and Efficacy of ABT-263 in Subjects With B-cell Chronic Lymphocytic Leukemia (CLL) Who Have Failed at Least One Prior Fludarabine-containing Regimen
This study has been withdrawn prior to enrollment.
(Sponsor has decided to not proceed with this study.)
Sponsor:
Abbott
Collaborator:
Genentech, Inc.
Information provided by:
Abbott
ClinicalTrials.gov Identifier:
NCT00918450
First received: May 22, 2009
Last updated: February 25, 2010
Last verified: February 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
| Study Status: | This study has been withdrawn prior to enrollment. |
|---|---|
| Study Completion Date: | No date given |
| Estimated Primary Completion Date: | December 2012 (Final data collection date for primary outcome measure) |